OCTANORM
Biological
Octapharma USA, Inc.
Total Payments
$341,872
Transactions
65
Doctors
4
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $66,020 | 15 | 4 |
| 2017 | $275,852 | 50 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $341,872 | 65 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SCGAM-01 | Octapharma USA, Inc. | $193,594 | 0 |
| SCGAM-03 | Octapharma USA, Inc. | $135,197 | 4 |
| SCGAM-02 | Octapharma USA, Inc. | $7,800 | 1 |
| URO-002 | Octapharma USA, Inc. | $5,280 | 0 |
Ad
Manufacturing Companies
- Octapharma USA, Inc. $341,872
Product Information
- Type Biological
- Total Payments $341,872
- Total Doctors 4
- Transactions 65
About OCTANORM
OCTANORM is a biological associated with $341,872 in payments to 4 healthcare providers, recorded across 65 transactions in the CMS Open Payments database. The primary manufacturer is Octapharma USA, Inc..
Payment data is available from 2017 to 2018. In 2018, $66,020 was paid across 15 transactions to 4 doctors.
The most common payment nature for OCTANORM is "Unspecified" ($341,872, 100.0% of total).
OCTANORM is associated with 4 research studies, including "SCGAM-01" ($193,594).